Mary Jane Attenburrow
Senior Clinical Research Fellow
- Clinical Lead, NIHR Oxford cognitive health Clinical Research Facility
- Hon Consultant Psychiatrist
My main area of interest is in research related to the understanding and treatment of Bipolar Disorder. My current interest is in developing a care model for the management of bipolar disorder using the electronic mood monitoring platform True Colours. I am interested in understanding what patients and the public want from research and am part of a group developing a PPI strategy. I am involved as an investigator and PI for a number of non commercial and commercial studies. As clinical lead for the NIHR Oxford cognitive health Clinical Research Facility, I am involved in facilitating complex cognitive health research working with PIs, research networks, local R&D, and the Oxford University Hospitals NHS Trust and Oxford Health NHS Foundation Trust. I have an Honorary Consultant Contract with Oxford Health NHS Foundation Trust and work in the Bipolar Disorder Research Clinic. I am on the editorial board for the British Journal of Psychiatry Advances.
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development
Cipriani A. et al, Molecular Psychiatry
Ketamine: A novel antidepressant with a fast onset of action?:Commentary on… cochrane corner
Smith K. and Attenburrow MJ., (2016), Advances in Psychiatric Treatment, 22, 216 - 221
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial.
Saunders KE. et al, (2016), Trials, 17
Does drug treatment reduce the risk of further self-harm or suicide?: COMMENTARY ON... COCHRANE CORNER
Smith K. and Attenburrow MJ., (2016), BJPscyh Advances, 22, 3 - 7
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.
Geddes JR. et al, (2016), Lancet Psychiatry, 3, 31 - 39
Comparative evaluation of quetiapine plus lamotrigine versus quetiapine monotherapy in people with bipolar depression: a randomized trial (CEQUEL)
Geddes JR. et al, (2015), BIPOLAR DISORDERS, 17, 50 - 51